Back to search
FDAFDA · Food and drugs·Recall number Z-0522-2025

Kreatech PapV-16, Flu labeled ISH probe, to detect presence of HPV-16 DNA inserts in human tissue, Model Number 40V016V495

Published December 4, 2024 · Recall initiated: November 1, 2024

Summary

FDA records medical device Class II recall Z-0522-2025, published December 4, 2024 and initiated November 1, 2024. Recalling firm: Kreatech Biotechnology Bv; Status: Ongoing; Reported quantity: 23 units; Lot: UDI-DI: (01)08718858480241 Lot Number: 00088454. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The DNA fragments for this specific lot number are too large, resulting in potential background around the cells due to suboptimal hybridization. An absence of signal could also be observed as a result of the suboptimal hybridization of the larger DNA fragments. The user may interpret potential background as a false positive result and an absence of signal as a false negative result, if proper positive and negative controls are not included.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Kreatech Biotechnology Bv
Distributor
US States: FL, NY
Lot
UDI-DI: (01)08718858480241 Lot Number: 00088454
Risk classification
Class II
Area (FDA)
device
Country
Netherlands

Related recalls

Questions about this recall

Was Kreatech PapV-16, Flu labeled ISH probe, to detect presence of HPV-16 DNA inserts in human tissue, Model Number 40V016V495 recalled?

Yes. FDA published recall Z-0522-2025 on December 4, 2024. Reported hazard: The DNA fragments for this specific lot number are too large, resulting in potential background around the cells due to suboptimal hybridization. An absence of signal could also be observed as a result of the suboptimal hybridization of the larger DNA fragments. The user may interpret potential background as a false positive result and an absence of signal as a false negative result, if proper positive and negative controls are not included.

What should I do if I have this product?

Voluntary: Firm initiated · Letter